Islet-1 overexpression in human mesenchymal stem cells promotes vascularization through monocyte chemoattractant protein-3

Stem Cells

Volumn 32, Issue 7, 2014, Pages 1843-1854

  Liu, Jia ^a,b   Li, Weiqiang ^c,d   Wang, Yinfen ^a   Fan, Wendong ^a   Li, Panlong ^c   Lin, Wanyi ^c   Yang, Daya ^a   Fang, Rong ^a   Feng, Mingzhe ^a   Hu, Chengheng ^a   Du, Zhimin ^a   Wu, Guifu ^a,b,e   Xiang, Andy Peng ^c,d  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c Ministry of Education   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

^e BEIJING HOSPITAL   (China)

Author keywords

Angiogenesis; Human mesenchymal stem cells; Islet 1; Vascularization

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; COL1A1 PROTEIN; ELONGATION FACTOR 1ALPHA; FATTY ACID BINDING PROTEIN 4; LENTIVIRUS VECTOR; MONOCYTE CHEMOTACTIC PROTEIN 3; OPN PROTEIN; OSTEOCALCIN; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CHAT; TRANSCRIPTION FACTOR HB9; TRANSCRIPTION FACTOR ISLET 1; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR LHX4; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; CCL7 PROTEIN, HUMAN; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1; LIM HOMEODOMAIN PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANGIOGENESIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSTEOBLAST; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CELL CULTURE; GENE EXPRESSION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; SCID MOUSE; SECRETION (PROCESS);

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CCL7; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIM-HOMEODOMAIN PROTEINS; MESENCHYMAL STROMAL CELLS; MICE, SCID; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSCRIPTION FACTORS;

EID: 84902576199     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1682     Document Type: Article

References (35)

1. Carmeliet P,. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-936.
2. Risau W, Flamme I,. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73-91.
3. Losordo DW, Dimmeler S,. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: Angiogenic cytokines. Circulation 2004; 109: 2487-2491.
4. Leeper NJ, Hunter AL, Cooke JP,. Stem cell therapy for vascular regeneration: Adult, embryonic, and induced pluripotent stem cells. Circulation 2010; 122: 517-526.
5. Losordo DW, Dimmeler S,. Therapeutic angiogenesis and vasculogenesis for ischemic disease: Part II: Cell-based therapies. Circulation 2004; 109: 2692-2697.
6. Au P, Tam J, Fukumura D, et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008; 111: 4551-4558.
7. Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006; 20: 661-669.
8. Wang WE, Yang D, Li L, et al. Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium. Circ Res 2013; 113: 288-300.
9. Kim SW, Lee DW, Yu LH, et al. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model. Cardiovasc Res 2012; 95: 495-506.
10. Pfaff SL, Mendelsohn M, Stewart CL, et al. Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 1996; 84: 309-320.
11. Cai CL, Liang X, Shi Y, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003; 5: 877-889.
12. Moretti A, Caron L, Nakano A, et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006; 127: 1151-1165.
13. Fonoudi H, Yeganeh M, Fattahi F, et al. ISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cells. PLoS One 2013; 8: e55577.
14. Suter DM, Cartier L, Bettiol E, et al. Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors. Stem Cells 2006; 24: 615-623.
15. Li W, Liu C, Qin J, et al. Efficient genetic modification of cynomolgus monkey embryonic stem cells with lentiviral vectors. Cell Transplant 2010; 19: 1181-1193.
16. Yu W, Chen Z, Zhang J, et al. Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Mol Cell Biochem 2008; 310: 11-18.
17. Wislet-Gendebien S, Laudet E, Neirinckx V, et al. Mesenchymal stem cells and neural crest stem cells from adult bone marrow: Characterization of their surprising similarities and differences. Cell Mol Life Sci 2012; 69: 2593-608.
18. Potier E, Ferreira E, Meunier A, et al. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 2007; 13: 1325-1331.
19. Cheng F, Ke Q, Chen F, et al. Protecting against wayward human induced pluripotent stem cells with a suicide gene. Biomaterials 2012; 33: 3195-3204.
20. Jaganathan BG, Ruester B, Dressel L, et al. Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells 2007; 25: 1966-1974.
21. Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, et al. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg 2007; 6: 593-597.
22. Liu JW, Dunoyer-Geindre S, Serre-Beinier V, et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 2007; 5: 826-834.
23. Ross JJ, Hong Z, Willenbring B, et al. Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest 2006; 116: 3139-3149.
24. Bahlmann FH, De Groot K, Spandau JM, et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004; 103: 921-926.
25. Silva EA, Kim ES, Kong HJ, Mooney DJ,. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci USA 2008; 105: 14347-52.
26. Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111: 150-156.
27. Ahlgren U, Pfaff SL, Jessell TM, et al. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 1997; 385: 257-260.
28. Guo T, Wang W, Zhang H, et al. ISL1 promotes pancreatic islet cell proliferation. PLoS One 2011; 6: e22387.
29. Barzelay A, Ben-Shoshan J, Entin-Meer M, et al. A potential role for islet-1 in post-natal angiogenesis and vasculogenesis. Thromb Haemost 2010; 103: 188-197.
30. Fang C, Wen G, Zhang L, et al. An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo. Cardiovasc Res 2013; 99: 146-155.
31. Alviano F, Fossati V, Marchionni C, et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007; 7: 11.
32. Yasuda M, Shimizu S, Tokuyama S, et al. A novel effect of polymorphonuclear leukocytes in the facilitation of angiogenesis. Life Sci 2000; 66: 2113-2121.
33. Kevil CG, Orr AW, Langston W, et al. Intercellular adhesion molecule-1 (ICAM-1) regulates endothelial cell motility through a nitric oxide-dependent pathway. J Biol Chem 2004; 279: 19230-19238.
34. Bousquenaud M, Schwartz C, Leonard F, et al. Monocyte chemotactic protein 3 is a homing factor for circulating angiogenic cells. Cardiovasc Res 2012; 94: 519-525.
35. Huang J, Zhang Z, Guo J, et al. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 2010; 106: 1753-1762.